Found 22 matching trials
Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma
PHASE2This phase II trial tests how well a combination of three immunotherapy dru...
Status
Active Not Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas
PHASE1This phase I/II trial tests the safety, side effects best dose and effect o...
Location
Mayo Clinic in Rochester
Retifanlimab with Bevacizumab and Hypofractionated Radiotherapy for the Treatment of Recurrent Glioblastoma
PHASE2This phase II trial tests how well retifanlimab with bevacizumab and hypofr...
Location
Mayo Clinic in Arizona
A Study of INCMGA00012 in Squamous Carcinoma of the Anal Canal Following Platinum-Based Chemotherapy (POD1UM-202)
PHASE2The purpose of this study is to assess the efficacy of INCMGA00012 in parti...
Location
City of Hope National Medical Center
Retifanlimab (INCMGA00012) and Telotristat Ethyl for the Treatment of Advanced Neuroendocrine Tumors and Carcinoid Syndrome
PHASE2This phase II trial studies the effect of retifanlimab and telotristat ethy...
Location
Multiple Locations
Safety Study of Enoblituzumab (MGA271) in Combination With Pembrolizumab or MGA012 in Refractory Cancer
PHASE1The purpose of this study is to evaluate the safety of enoblituzumab (MGA27...
Enoblituzumab Plus MGA012 or MGD013 in Squamous Cell Carcinoma of the Head and Neck
PHASE2This is an open-label study designed to evaluate safety and efficacy of eno...
Location
Multiple Locations
Enoblituzumab Plus Retifanlimab or Tebotelimab in Head and Neck Cancer
PHASE2This is a Phase 2 study of enoblituzumab combined with either retifanlimab ...
Location
University of Maryland, Greenebaum Comprehensive Cancer Center
MGD009/MGA012 Combination in Relapsed/Refractory Cancer
PHASE1The purpose of this study is to evaluate the safety and tolerability, pharm...
Location
City of Hope Medical Center
Short-term Fasting Prior to PD-1/PD-L1 Inhibitor Therapy for of Advanced or Metastatic Skin Malignancy
PHASE1This trial studies the side effects of short-term fasting in patients with ...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center